Vivos Therapeutics, Inc. · NASDAQ:VVOS
V-CO Investors LLC reported a 7.70% stake in Vivos Therapeutics, Inc. (Schedule 13D)
Event Jun 9, 2025 · Filed Jun 16, 2025
V-CO Investors LLC reported a 7.70% stake in Vivos Therapeutics, Inc., 514,498 shares, with active intent on Jun 9, 2025. Filed Jun 16, 2025 (Schedule 13D).
- Stake
- 7.70%
- Shares
- 514,498
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| V-CO Investors LLC | 7.70% | 514,498 |
| V-Co Investors 2 LLC | 12.30% | 828,000 |
| SP Manager LLC | 19.90% | 1,342,498 |
| Michael C. Skaff | 19.90% | 1,342,498 |
Source
Related
- Vivos Therapeutics, Inc.
- V-CO Investors LLC
- Vivos Therapeutics, Inc. shareholders
- Schedule 13G · V-CO Investors LLC · Dec 20, 2024
- Form 4 · Huntsman Ronald Kirk · Sep 18, 2026
- Schedule 13G/A · Streeterville Capital LLC · Sep 3, 2026
- Form 4 · Amman Bradford K. · Aug 26, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Streeterville Capital LLC · Aug 11, 2026